CUSIP: 89365K305
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,918,155
-
Share change
-
+158,103
-
Total reported value
-
$1,774,000
-
Price per share
-
$0.92
-
Number of holders
-
14
-
Value change
-
+$143,093
-
Number of buys
-
6
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP 89365K305?
CUSIP 89365K305 identifies TBIO - TRANSGENOMIC INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2015
-
Previous quarter:
Q2 2015
Recent filing periods for CUSIP 89365K305:
Institutional Holders of TRANSGENOMIC INC - COM NEW (TBIO) as of Q3 2015
As of 30 Sep 2015,
TRANSGENOMIC INC - COM NEW (TBIO) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,918,155 shares.
The largest 10 holders included
Third Security, LLC, WHITE PINE CAPITAL LLC, FMR LLC, Trellus Management Company, LLC, VANGUARD GROUP INC, Potomac Capital Management, Inc., WOLVERINE ASSET MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, CITADEL ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.